NCT01246362View on ClinicalTrials.gov

Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Knee Osteoarthritis
Interventions
DRUG

Control

Given placebo

DRUG

Etoricoxib

Given etoricoxib 120mg 24 hours preoperatively and 120mg 2 hours preoperatively

Trial Locations (1)

169608

Singapore General Hospital, Singapore

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Singapore General Hospital

OTHER

NCT01246362 - Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter